维普期刊资源整合服务平台（V6.5）

105篇 您的检索式：作者名="BRANCACCIO D"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Hyperparathyroidism and anemia in ure mic subjects:a combined the rapeutic approach显示文摘	Brancaccio D Cozzolino M Gallieni M	2004	J Am Soc- Nephrol2004，15，1：	1
2	Inflammation,CRP,cal- cium overload and a high calcium phosphate product:A liaisondangerouse显示文摘	Brancaccio D Tetta C Gallieni M	2002	Nephrology Dialysis Transplantation2002，17，2：	1
3	Inflamation,CRP,calcium overload and a high calcium-phosphate product:A'liaison dangerous'显示文摘	Brancaccio D Tetta C Gallioni M	2000	Nephrol Dial Transplant2000，17，：	1
4	Inherited thrombophilic risk factors and venous throraboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism显示文摘	Margaglione M Brancaccio V De Lucia D	2000	Chest2000，118，5：	1
5	Emerging role for the vitamin D recepter activator (VDRA),paricalcitol,in the treatment of secondary hyperparathyroidism显示文摘	Cozzoliino M Brancaccio D		0，，：	1
6	Recent advances in intravenous calcitriol treatment显示文摘	Brancaccio D Gallieni M	1994	Current Opinion in Nephrology and Hypertension1994，3，4：	1
7	Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects:a cost consequences analysis of data from the FARO study显示文摘	Roggeri DP Mazzaferro S Brancaccio D	2012	J Med Econ2012，15，6：	1
8	Genetic modulation of oral anticoagulation with warfarin显示文摘	Margaglione M Colaizzo D D'Andrea G Brancaccio V Ciampa A Grandone E	2000	Thromb Haemost2000，84，：	1
9	Trace elements in dialysis fluids and assessment of the exposure of patients on regular hemodialysis,hemofiltration and continuous ambulatory peritoneal dialysis显示文摘	ese P Gallieni M Brancaccio D		0，，04：	1
10	Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach 显示文摘	Brancaccio D Cozzolino M Gallieni M	2004	J Am Soc Nephrol2004，15，1：	1
11	Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies 显示文摘	Brancaccio D Bommer J Coyne D	2007	Drugs2007，67，14：	1
12	Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease显示文摘	Cozzolino M Brancaccio D	2007	Expert Opin Emerg Drugs2007，12，3：	1
13	Fathogenesis of vascular calcification in chronic kidney disease 显示文摘	Cozzolino M Brancaccio D Gallieni M	2005	Kidney Int2005，68，：	1
14	Hyperparathyroidism and anemia in ure mic subjects:a combined the rapeutic approach显示文摘	Brancaccio D Cozzolino M Gallieni M	2004	J Am Soc Nephrol2004，15，1：	1
15	Hyperparathyroidism and anemia in uremic subjects:a combined the rapeutic approach显示文摘	Brancaccio D Cozzolino M Gallieni M	2004	J Am Soc Nephrol2004，15，1：	1
16	Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism显示文摘	Cozzolino M Brancaccio D	2008	Expert Opin Pharmacother2008，9，6：	1
17	Pathogenesis of vascular calcification in chronic kidney disease 显示文摘	Cozzolino M Brancaccio D Gallieni M	2005	Kidney Int2005，68，2：	1
18	Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease 显示文摘	Cozzolino M Brancaccio D	2007	Expert Opin Emerg Drugs2007，12，3：	1
19	Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach显示文摘	Brancaccio D Cozzolino M Gallieni M	2004	J Am Soc Nephrol2004，151，：	1
20	Hyperparathyroid- ism and anemia in uremin subjects: a combined therapeutic ap- proach显示文摘	Brancaccio D Cozzolino M Gallieni M	2004	J Am Soc Nephrol2004，15，1：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示